IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories net income 1991–2026

IDEXX Laboratories earned 317.15M USD in Q3 FY2026, the three months to 30 September 2026, up 15.5% on the same quarter a year before. IDEXX Laboratories's net income over the last twelve months was 1.18B USD, up 15.1% on the twelve months before. In fiscal year 2025 it earned 1.06B USD, up 19.3% on the year before.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Net income

Net income · +18.6% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20261.18B+15.06%25.36%4.66B
FY202531 Dec 20251.06B+19.33%24.62%4.30B
FY202431 Dec 2024887.87M+5.07%22.78%3.90B
FY202331 Dec 2023845.04M+24.44%23.08%3.66B
FY202231 Dec 2022679.09M-8.83%20.17%3.37B
FY202131 Dec 2021744.85M+28.03%23.17%3.22B
FY202031 Dec 2020581.78M+36.02%21.49%2.71B
FY201931 Dec 2019427.72M+13.44%17.77%2.41B
FY201831 Dec 2018377.03M+43.28%17.04%2.21B
FY201731 Dec 2017263.14M+18.51%13.36%1.97B
FY201631 Dec 2016222.05M+15.60%12.51%1.78B
FY201531 Dec 2015192.08M+5.59%11.99%1.60B
FY201431 Dec 2014181.91M-3.14%12.24%1.49B
FY201331 Dec 2013187.80M+5.35%13.64%1.38B
FY201231 Dec 2012178.27M+10.19%13.78%1.29B
FY201131 Dec 2011161.79M+14.51%13.28%1.22B
FY201031 Dec 2010141.28M+15.59%12.80%1.10B
FY200931 Dec 2009122.23M+5.21%11.85%1.03B
FY200831 Dec 2008116.17M+23.57%11.34%1.02B
FY200731 Dec 200794.01M+0.36%10.19%922.56M
FY200631 Dec 200693.68M+19.71%12.67%739.12M
FY200531 Dec 200578.25M-0.10%12.26%638.10M
FY200431 Dec 200478.33M+37.21%14.26%549.18M
FY200331 Dec 200357.09M+25.78%11.99%475.99M
FY200231 Dec 200245.39M+20.65%11.00%412.67M
FY200131 Dec 200137.62M+2.70%9.74%386.08M
FY200031 Dec 200036.63M+12.37%9.97%367.43M
FY199931 Dec 199932.60M—9.15%356.20M
FY199831 Dec 1998-15.20M—-4.75%319.90M
FY199731 Dec 1997-21.10M-164.72%-8.02%263.00M
FY199631 Dec 199632.60M+51.63%12.18%267.70M
FY199531 Dec 199521.50M+61.65%11.40%188.60M
FY199431 Dec 199413.30M+37.11%10.52%126.40M
FY199331 Dec 19939.70M+97.96%10.42%93.10M
FY199231 Dec 19924.90M+53.13%8.49%57.70M
FY199131 Dec 19913.20M—10.49%30.50M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about IDEXX Laboratories's profit

Source: Financial Modeling Prep